Half-year report · HY
4572.TEDINET S100YV1G
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥401m | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥579m | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥251m | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | −¥954m | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥2.1bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥1.8bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥1.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥920m | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | −¥408m | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥309m | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥517m | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥517m | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥915m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥995m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥11m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥25m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.5bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥605m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥14m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-53.13 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-113.62 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-55.29 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | -23.9% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.1% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| Drug Discovery Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥1.0bn |
| Drug Discovery Support Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥401m |
| Drug Discovery Support Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥401m |
| Drug Discovery Support Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥67m |
| Drug Discovery Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥1.0bn |
| Drug Discovery Support Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥251m |
| Drug Discovery Support Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥251m |
| Drug Discovery Support Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥51m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 442
| Item | Context | Value | Unit |
|---|---|---|---|
| Income before income taxes | Prior1InterimDuration | -1055340000 | JPY |
| Income before income taxes | InterimDuration | -1038288000 | JPY |
| Income taxes current | Prior1InterimDuration | 1985000 | JPY |
| Income taxes current | InterimDuration | 1494000 | JPY |
| Income taxes deferred | Prior1InterimDuration | -1270000 | JPY |
| Income taxes deferred | InterimDuration | － | JPY |
| Income taxes | Prior1InterimDuration | 714000 | JPY |
| Income taxes | InterimDuration | 1494000 | JPY |
| Profit loss | Prior1InterimDuration | -1056054000 | JPY |
| Profit loss | InterimDuration | -1039782000 | JPY |
| Profit loss attributable to owners of parent | Prior1InterimDuration | -1056054000 | JPY |
| Profit loss attributable to owners of parent | InterimDuration | -1039782000 | JPY |
| Profit loss | Prior1InterimDuration | -1056054000 | JPY |
| Profit loss | InterimDuration | -1039782000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1InterimDuration | -2737000 | JPY |
| Valuation difference on available for sale securities net of tax oci | InterimDuration | 3092000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1InterimDuration | -27431000 | JPY |
| Foreign currency translation adjustment net of tax oci | InterimDuration | 10564000 | JPY |
| Other comprehensive income | Prior1InterimDuration | -30169000 | JPY |
| Other comprehensive income | InterimDuration | 13656000 | JPY |
| Comprehensive income | Prior1InterimDuration | -1086224000 | JPY |
| Comprehensive income | InterimDuration | -1026125000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1InterimDuration | -1086224000 | JPY |
| Comprehensive income attributable to owners of the parent | InterimDuration | -1026125000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1InterimDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | InterimDuration | － | JPY |
| Income before income taxes | Prior1InterimDuration | -1055340000 | JPY |
| Income before income taxes | InterimDuration | -1038288000 | JPY |
| Impairment loss ope cf | Prior1InterimDuration | 315000 | JPY |
| Impairment loss ope cf | InterimDuration | 12350000 | JPY |
| Interest income ope cf | Prior1InterimDuration | -2999000 | JPY |
| Interest income ope cf | InterimDuration | -819000 | JPY |
| Dividends income ope cf | Prior1InterimDuration | -1528000 | JPY |
| Dividends income ope cf | InterimDuration | -1300000 | JPY |
| Interest expenses ope cf | Prior1InterimDuration | 895000 | JPY |
| Interest expenses ope cf | InterimDuration | 34219000 | JPY |
| Share based compensation expenses ope cf | Prior1InterimDuration | 11150000 | JPY |
| Share based compensation expenses ope cf | InterimDuration | 5301000 | JPY |
| Stock issuance cost ope cf | Prior1InterimDuration | 91000 | JPY |
| Stock issuance cost ope cf | InterimDuration | 936000 | JPY |
| Issuance cost of subscription rights to sharea ope cf | Prior1InterimDuration | － | JPY |
| Issuance cost of subscription rights to sharea ope cf | InterimDuration | 11613000 | JPY |
| Loss on redemption of bonds ope cf | Prior1InterimDuration | － | JPY |
| Loss on redemption of bonds ope cf | InterimDuration | 20138000 | JPY |
| Foreign exchange losses gains ope cf | Prior1InterimDuration | 1029000 | JPY |
| Foreign exchange losses gains ope cf | InterimDuration | 3583000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1InterimDuration | 11624000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | InterimDuration | -14697000 | JPY |
| Decrease increase in inventories ope cf | Prior1InterimDuration | -9446000 | JPY |
| Decrease increase in inventories ope cf | InterimDuration | 3968000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |